Dr. David Alboukrek, MD

Dr. Alboukrek practices at Pardo Forstot Baca & Alboukrek PA in Delray Beach, Florida.

Dr. Alboukrek's NPI, 1255434031, was assigned on September 6, 2006. Dr. Alboukrek graduated from Universidad de San Carlos FOMS in 1982. Dr. Alboukrek holds Florida license ME 68234.

Dr. Alboukrek's primary practice is Pardo Forstot Baca & Alboukrek PA, at 5162 Linton Blvd, Delray Beach, FL 33484 in Palm Beach County. The practice phone is (561) 368-5611.

Dr. Alboukrek's primary practice is Pardo Forstot Baca & Alboukrek PA in Delray Beach, Florida. Dr. Alboukrek is also affiliated with Delray Medical Center. The medical group on file is CORA Physical Therapy, Spanish Springs. Dmand AI also links Dr. Alboukrek to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alboukrek practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Alboukrek's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Alboukrek is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Alboukrek's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists arteritis, arthritis, fluid in a joint, gout, joint pain, lupus, muscle pain, fibromyalgia, and limb pain and osteoporosis among the conditions Dr. Alboukrek treats.

CMS data shows 64,535 Medicare services from Dr. Alboukrek across 39 procedure codes in 2024, for 1,403 Medicare patients. Medicare paid $1,071,526 for them. Every service was in an office.

CMS counts 1,403 Medicare patients who saw Dr. Alboukrek in 2024. The largest group is 75 to 84, with 634 patients. 75% of them have high cholesterol, and 75% have osteoporosis. 1% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alboukrek's median patient age at 72, with 80% women.

In 2024, Dr. Alboukrek wrote 1,869 Medicare Part D claims for 438 patients. 89% of them were for generic drugs. CMS names the drug for 1,800 of them, across 25 drugs with 11 or more claims each, at $690,627 in total drug cost. In 2023, CMS named 1,883 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Alboukrek for performance year 2024, reported as part of a group. Dr. Alboukrek accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Alboukrek in 2019. The most frequent topics are Predictive Value of Tests. Dr. Alboukrek's most frequent co-authors are Adam Souhail Aldahan, MD, Nabil Benhayoun, MD and Hector Hugo Gonzalez, MD.

CMS Open Payments shows 851 general payments to Dr. Alboukrek from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Abbvie Inc. paid the most, $2,732.

Dmand AI lists 4 awards for Dr. Alboukrek, most recently Regional Top Doctor in 2014. Dr. Alboukrek serves on Medical Staff Excellence Committee (peer review).

Dr. Alboukrek graduated from Universidad de San Carlos FOMS in 1982. Dr. Alboukrek is a member of ACR.

Dr. Alboukrek is in network with 2 carriers, including Aetna and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.